Genetic variation in the EGFR gene and the risk of glioma in a Chinese Han population

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Hou, Wu Gang ^a   Ai, Wen Bo ^b   Bai, Xiao Guang ^a   Dong, Hai Long ^a   Li, Zhen ^b   Zhang, Yuan Qiang ^b   Xiong, Li Ze ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARCINOGENESIS; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; EGFR GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLIOMA; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOMA; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK; YOUNG ADULT;

EID: 84861468072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037531     Document Type: Article

References (26)

1. Liu Y, Shete S, Hosking F, Robertson L, Houlston R, et al. (2010) Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev 20: 239-244.
2. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41: 905-908.
3. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
4. Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, et al. (2008) Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet 17: 800-805.
5. Zhao L, Jiang X, Peng F, Zhou R, (2010) Correlation between epidermal growth factor receptor (EGFR) intron1 (CA) n microsatellite polymorphism, lymph node metastasis and expression of EGFR in non-small cell lung cancer. Zhonghua Bing Li Xue Za Zhi 39: 476-477.
6. Sasaki H, Okuda K, Shimizu S, Takada M, Kawahara M, et al. (2009) EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer. J Cancer Res Clin Oncol 135: 313-318.
7. Kharrat N, Al'Fadhli S, Rebai M, Aifa MS, Kallel I, et al. (2007) (AC) dinucleotide repeat polymorphism in intron 1 of human EGFR shows ethnic specificities and high evidence for association with breast cancer. Int J Biol Markers 22: 258-264.
8. Perez CA, Chen H, Shyr Y, Courtney R, Zheng W, et al. (2010) The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer. J Urol 183: 2062-2069.
9. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B, (2008) Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer. Oncol Res 17: 167-174.
10. Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, et al. (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A 89: 2965-2969.
11. Hedman H, Henriksson R, (2007) LRIG inhibitors of growth factor signalling- double-edged swords in human cancer? Eur J Cancer 43: 676-682.
12. Andersson U, Schwartzbaum J, Wiklund F, Sjostrom S, Liu Y, et al. (2010) A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol 49: 767-775.
13. Hirschhorn JN, Daly MJ, (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6: 95-108.
14. Perneger TV, (1998) What's wrong with Bonferroni adjustments. BMJ 316: 1236-1238.
15. Gan HK, Kaye AH, Luwor RB, (2009) The EGFRvIII variant in glioblastoma multiforme. J Clin Neurosci 16: 748-754.
16. Ohgaki H, Kita D, Favereaux A, Huang H, Homma T, et al. (2006) Brain tumors in S100beta-v-erbB transgenic rats. J Neuropathol Exp Neurol 65: 1111-1117.
17. Weiss WA, Burns MJ, Hackett C, Aldape K, Hill JR, et al. (2003) Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res 63: 1589-1595.
18. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ, (2004) A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 64: 1220-1223.
19. Kochl S, Niederstatter H, Parson W, (2005) DNA extraction and quantitation of forensic samples using the phenol-chloroform method and real-time PCR. Methods Mol Biol 297: 13-30.
20. Gabriel S, Ziaugra L, Tabbaa D, (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet, Chapter 2, Unit 2.12.
21. Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, et al. (2007) High-throughput oncogene mutation profiling in human cancer. Nat Genet 39: 347-351.
22. Adamec C, (1964) Example of the Use of the Nonparametric Test. Test X2 for Comparison of 2 Independent Examples. Cesk Zdrav 12: 613-619.
23. Bland JM, Altman DG, (2000) Statistics notes: the odds ratio. BMJ 320: 1468.
24. Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, et al. (2007) PLINK: a toolset for whole-genome association and population-based linkage analysis. American Journal of Human Genetics 81.
25. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
26. Shi YY, He L, (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15: 97-98.